Xinhua Pharma Obtains Three Drug Certificates from Chinese Regulator

MT Newswires Live

09/18

Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) and a unit recently obtained drug registration certificates for three drugs from China's National Medical Products Administration.

The company got a certificate for Levocarnitine Oral Solution, used for the treatment of primary systemic carnitine deficiency.

Its Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution, which is used for bowel cleaning in adults before any operation requiring intestinal cleansing, also got a registration certificate.

Unit Shandong Zibo Xincat Pharmaceutical got the third certificate for its Donepezil Hydrochloride Orally Disintegrating Tablets for the treatment of mild, moderate or severe symptoms of Alzheimer's disease.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2668940597"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2668940597\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2668940597?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-18 18:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2668940597","market":"fut","top_or_hot":-1,"title":"Xinhua Pharma Obtains Three Drug Certificates from Chinese Regulator","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (SHE:000756, HKG:0719) and a unit recently obtained drug registration certificates for three drugs from China's National Medical Products Administration.</p><p>The company got a certificate for Levocarnitine Oral Solution, used for the treatment of primary systemic carnitine deficiency.</p><p>Its Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution, which is used for bowel cleaning in adults before any operation requiring intestinal cleansing, also got a registration certificate.</p><p>Unit Shandong Zibo Xincat Pharmaceutical got the third certificate for its Donepezil Hydrochloride Orally Disintegrating Tablets for the treatment of mild, moderate or severe symptoms of Alzheimer's disease.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xinhua Pharma Obtains Three Drug Certificates from Chinese Regulator</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXinhua Pharma Obtains Three Drug Certificates from Chinese Regulator\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-09-18 18:51</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (SHE:000756, HKG:0719) and a unit recently obtained drug registration certificates for three drugs from China's National Medical Products Administration.</p><p>The company got a certificate for Levocarnitine Oral Solution, used for the treatment of primary systemic carnitine deficiency.</p><p>Its Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution, which is used for bowel cleaning in adults before any operation requiring intestinal cleansing, also got a registration certificate.</p><p>Unit Shandong Zibo Xincat Pharmaceutical got the third certificate for its Donepezil Hydrochloride Orally Disintegrating Tablets for the treatment of mild, moderate or severe symptoms of Alzheimer's disease.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"製藥","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2668940597","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2668940597","pubTimestamp":1789728716,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shandong Xinhua Pharmaceutical  and a unit recently obtained drug registration certificates for three drugs from China's National Medical Products Administration.The company got a certificate for Levocarnitine Oral Solution, used for the treatment of primary systemic carnitine deficiency.Its Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution, which is used for bowel cleaning in adults before any operation requiring intestinal cleansing, also got a registration certificate.Unit Shandong Zibo Xincat Pharmaceutical got the third certificate for its Donepezil Hydrochloride Orally Disintegrating Tablets for the treatment of mild, moderate or severe symptoms of Alzheimer's disease.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","BK0164":"国企混改","BK1515":"抗疫概念","000756":"新华制药","BK0239":"医药制造","00719":"山东新华制药股份"},"translate_title":"新华制药获得中国监管机构三项药品证书","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00719":0.9,"000756":0.9},"content_text":"Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) and a unit recently obtained drug registration certificates for three drugs from China's National Medical Products Administration.The company got a certificate for Levocarnitine Oral Solution, used for the treatment of primary systemic carnitine deficiency.Its Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution, which is used for bowel cleaning in adults before any operation requiring intestinal cleansing, also got a registration certificate.Unit Shandong Zibo Xincat Pharmaceutical got the third certificate for its Donepezil Hydrochloride Orally Disintegrating Tablets for the treatment of mild, moderate or severe symptoms of Alzheimer's disease.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}